	Ebitda		Date
Agios Pharmaceuticals	USD -115.49M	10.3M	2025-09
ALKERMES	USD 100.31M	21.24M	2025-12
Alterity Therapeutics Limited	AUD -7.72M	2.99M	2023-06
Amgen	USD 5.14B	775M	2025-12
Baxter International	USD 426M	36M	2025-09
Biogen	USD 573.2M	253.7M	2025-12
Bristol-Myers Squibb	USD 4.24B	967M	2025-09
Cara Therapeutics	USD -2.39M	3.16M	2025-03
Cipla	INR 12.55B	6.4B	2025-12
Dr.Reddys Laboratories	INR 20.89B	117M	2025-12
Eisai	JPY 30.1B	6.62B	2025-12
Eli Lilly	USD 7.88B	378.1M	2025-09
Esperion Therapeutics	USD -27.51M	9.5M	2023-09
Exelixis	USD 248.93M	28.02M	2025-09
Gilead Sciences	USD 4.03B	628M	2025-09
GlaxoSmithKline	GBP 3.36B	179M	2025-09
Grifols	EUR 482.04M	7.04M	2025-09
Halozyme Therapeutics	USD 21.9M	226.34M	2025-12
Incyte	USD 414.5M	92.42M	2025-12
Ionis Pharmaceuticals	USD -157.12M	307.36M	2025-09
Ironwood Pharmaceuticals	USD 81.81M	31.71M	2025-09
Karyopharm Therapeutics	USD -26.2M	1.83M	2024-09
MacroGenics	USD 21.95M	55.39M	2025-09
Merck	USD 8.39B	1.97B	2025-09
Nektar Therapeutics	USD -31.81M	70K	2023-09
Neurocrine Biosciences	USD 218.4M	28.3M	2025-12
Novartis	USD 5.88B	290M	2025-09
Pfizer	USD 6.08B	351M	2025-09
Roche Holding	CHF 12.68B	2.36B	2024-06
Sarepta Therapeutics	USD -168.03M	294.45M	2025-09
Takeda	JPY 448.13B	173.98B	2025-12
Teva Pharmaceutical Industries	USD 1.64B	243M	2025-12
Xencor	USD -51.05M	55.28M	2025-12

Nektar Therapeutics - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2026.